CN103098795B - 一种银离子杀菌分散片及其制备工艺和在清洁果蔬残留细菌中的应用 - Google Patents
一种银离子杀菌分散片及其制备工艺和在清洁果蔬残留细菌中的应用 Download PDFInfo
- Publication number
- CN103098795B CN103098795B CN201310031608.6A CN201310031608A CN103098795B CN 103098795 B CN103098795 B CN 103098795B CN 201310031608 A CN201310031608 A CN 201310031608A CN 103098795 B CN103098795 B CN 103098795B
- Authority
- CN
- China
- Prior art keywords
- silver ion
- sterilization
- mix
- subsequent use
- combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001954 sterilising effect Effects 0.000 title claims abstract description 49
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 title claims abstract description 46
- 241000894006 Bacteria Species 0.000 title claims description 32
- 235000012055 fruits and vegetables Nutrition 0.000 title claims description 32
- 238000002360 preparation method Methods 0.000 title claims description 18
- 239000007919 dispersible tablet Substances 0.000 title abstract 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 36
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims abstract description 34
- 239000002245 particle Substances 0.000 claims abstract description 29
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims abstract description 19
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 18
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 17
- 108010024636 Glutathione Proteins 0.000 claims abstract description 16
- 229960003180 glutathione Drugs 0.000 claims abstract description 16
- 230000002147 killing effect Effects 0.000 claims abstract description 16
- 239000000945 filler Substances 0.000 claims abstract description 14
- 239000000314 lubricant Substances 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 9
- -1 silver ions Chemical class 0.000 claims abstract description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 29
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 24
- 239000004615 ingredient Substances 0.000 claims description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- 238000005516 engineering process Methods 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 239000007884 disintegrant Substances 0.000 claims description 13
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 12
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 12
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 12
- 239000011734 sodium Substances 0.000 claims description 12
- 229910052708 sodium Inorganic materials 0.000 claims description 12
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 12
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 12
- 239000000853 adhesive Substances 0.000 claims description 11
- 230000001070 adhesive effect Effects 0.000 claims description 11
- 229920002472 Starch Polymers 0.000 claims description 10
- 239000008107 starch Substances 0.000 claims description 10
- 235000019698 starch Nutrition 0.000 claims description 10
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 9
- 239000011975 tartaric acid Substances 0.000 claims description 9
- 235000002906 tartaric acid Nutrition 0.000 claims description 9
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 8
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 229910000503 Na-aluminosilicate Inorganic materials 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 239000000741 silica gel Substances 0.000 claims description 7
- 229910002027 silica gel Inorganic materials 0.000 claims description 7
- 239000000429 sodium aluminium silicate Substances 0.000 claims description 7
- 235000012217 sodium aluminium silicate Nutrition 0.000 claims description 7
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 7
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 238000007907 direct compression Methods 0.000 claims description 6
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 6
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 6
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 6
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical class OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 5
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 5
- 229940045902 sodium stearyl fumarate Drugs 0.000 claims description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 4
- 239000001856 Ethyl cellulose Substances 0.000 claims description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- 229920000881 Modified starch Polymers 0.000 claims description 4
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 4
- 235000013539 calcium stearate Nutrition 0.000 claims description 4
- 239000008116 calcium stearate Substances 0.000 claims description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 4
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 4
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 4
- 229920001249 ethyl cellulose Polymers 0.000 claims description 4
- 239000001530 fumaric acid Substances 0.000 claims description 4
- 229960003511 macrogol Drugs 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 235000015424 sodium Nutrition 0.000 claims description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 4
- 229920006184 cellulose methylcellulose Polymers 0.000 claims description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 3
- 229940083542 sodium Drugs 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 229940032147 starch Drugs 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 239000002270 dispersing agent Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract description 16
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 9
- 230000001580 bacterial effect Effects 0.000 abstract description 9
- 206010059866 Drug resistance Diseases 0.000 abstract description 8
- 229910052709 silver Inorganic materials 0.000 abstract description 7
- 239000004332 silver Substances 0.000 abstract description 7
- 230000006378 damage Effects 0.000 abstract description 4
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 abstract description 3
- 239000002547 new drug Substances 0.000 abstract description 3
- 229940068041 phytic acid Drugs 0.000 abstract description 3
- 244000052616 bacterial pathogen Species 0.000 abstract description 2
- 210000000234 capsid Anatomy 0.000 abstract description 2
- 230000002045 lasting effect Effects 0.000 abstract description 2
- 230000010534 mechanism of action Effects 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 2
- 102000053602 DNA Human genes 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 2
- 239000007767 bonding agent Substances 0.000 abstract 1
- 238000010790 dilution Methods 0.000 description 31
- 239000012895 dilution Substances 0.000 description 31
- 230000000694 effects Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- 239000004094 surface-active agent Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000575 pesticide Substances 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241001478240 Coccus Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000588769 Proteus <enterobacteria> Species 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 239000003905 agrochemical Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000000474 Poliomyelitis Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 238000011017 operating method Methods 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241001347978 Major minor Species 0.000 description 1
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000001967 plate count agar Substances 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 210000001243 pseudopodia Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310031608.6A CN103098795B (zh) | 2013-01-28 | 2013-01-28 | 一种银离子杀菌分散片及其制备工艺和在清洁果蔬残留细菌中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310031608.6A CN103098795B (zh) | 2013-01-28 | 2013-01-28 | 一种银离子杀菌分散片及其制备工艺和在清洁果蔬残留细菌中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103098795A CN103098795A (zh) | 2013-05-15 |
CN103098795B true CN103098795B (zh) | 2014-07-02 |
Family
ID=48307254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310031608.6A Expired - Fee Related CN103098795B (zh) | 2013-01-28 | 2013-01-28 | 一种银离子杀菌分散片及其制备工艺和在清洁果蔬残留细菌中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103098795B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103918712A (zh) * | 2014-04-20 | 2014-07-16 | 阎昭良 | 用于牙具、食具的清洗泡腾片制备及其使用方法 |
CN105454291A (zh) * | 2015-11-23 | 2016-04-06 | 中国海洋石油总公司 | 一种纳米银泡腾片杀菌剂及其制备方法 |
CN107320490A (zh) * | 2016-04-29 | 2017-11-07 | 三九军大药业(厦门)有限公司 | 一种银离子液的制备方法及其在脚气喷剂中的应用 |
CN110191871A (zh) * | 2017-01-20 | 2019-08-30 | 株式会社钟化 | 包含谷胱甘肽的粒状肥料 |
CN107625963B (zh) * | 2017-09-20 | 2021-03-30 | 深圳大学 | 一种纳米结构的杀菌复合药物及其制备方法 |
CN108391663A (zh) * | 2018-03-29 | 2018-08-14 | 蚌埠医学院 | 一种新型抗菌清洁泡腾片 |
CN109874787B (zh) * | 2019-04-23 | 2020-09-25 | 山东农业大学 | γ-氨基丁酸在降低蔬菜农药残留中的应用 |
CN111442594A (zh) * | 2020-03-06 | 2020-07-24 | 惠而浦(中国)股份有限公司 | 一种可控湿的冰箱 |
CN113966748A (zh) * | 2021-11-12 | 2022-01-25 | 嘉兴爱邦日用品有限公司 | 一种稳定持久杀菌芳香片的制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1344494A (zh) * | 2000-09-28 | 2002-04-17 | 舟山明日纳米材料有限公司 | 纳米载银抗菌剂的制备方法 |
CN1383723A (zh) * | 2002-04-29 | 2002-12-11 | 兴国纳米科技实业有限公司 | 纳米抗菌粉体及其制备工艺 |
CN1965662A (zh) * | 2006-11-15 | 2007-05-23 | 陈罘杲 | 一种纳米果蔬保鲜液膜及其制备方法 |
WO2008122131A1 (en) * | 2007-04-04 | 2008-10-16 | Perlen Converting Ag | Antimicrobial material |
WO2011073193A1 (en) * | 2009-12-15 | 2011-06-23 | Closed Stock Company "Institute Of Applied Nanotechnology" | Method for antiseptic processing of the surface of a product made of silicone rubber materials |
-
2013
- 2013-01-28 CN CN201310031608.6A patent/CN103098795B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1344494A (zh) * | 2000-09-28 | 2002-04-17 | 舟山明日纳米材料有限公司 | 纳米载银抗菌剂的制备方法 |
CN1383723A (zh) * | 2002-04-29 | 2002-12-11 | 兴国纳米科技实业有限公司 | 纳米抗菌粉体及其制备工艺 |
CN1965662A (zh) * | 2006-11-15 | 2007-05-23 | 陈罘杲 | 一种纳米果蔬保鲜液膜及其制备方法 |
WO2008122131A1 (en) * | 2007-04-04 | 2008-10-16 | Perlen Converting Ag | Antimicrobial material |
WO2011073193A1 (en) * | 2009-12-15 | 2011-06-23 | Closed Stock Company "Institute Of Applied Nanotechnology" | Method for antiseptic processing of the surface of a product made of silicone rubber materials |
Also Published As
Publication number | Publication date |
---|---|
CN103098795A (zh) | 2013-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103098795B (zh) | 一种银离子杀菌分散片及其制备工艺和在清洁果蔬残留细菌中的应用 | |
CN106342946B (zh) | 一种空气净化消毒剂及制备方法 | |
JP6803896B2 (ja) | 次亜塩素酸を含む抗微生物剤 | |
CN104688648B (zh) | 一种口腔用组合物及其制备方法 | |
CN106259509A (zh) | 一种天然植物消毒剂及其制备方法 | |
CN108566954A (zh) | 一种消毒剂及其制备方法和应用 | |
CN106234439A (zh) | 一种超级细菌抗菌消毒剂及其制备方法和用途 | |
CN103977155A (zh) | 免洗复方手消毒液及其制备方法 | |
CN101578984A (zh) | 肉桂醛、丁香酚和柠檬酸复配杀藻剂 | |
CN103783089B (zh) | 一种用于餐具及厨具消毒的复方中草药消毒剂 | |
CN106234388B (zh) | 一种含苯并烯氟菌唑和小檗碱的农药组合物 | |
CN103918712A (zh) | 用于牙具、食具的清洗泡腾片制备及其使用方法 | |
CN108157358A (zh) | 一种消毒液及其制备方法 | |
CN110012904A (zh) | 一种三氯异氰尿酸泡腾消毒片及其制备方法 | |
CN101142916A (zh) | 一元二氧化氯消毒片及其生产方法 | |
CN102349548A (zh) | 一种以噬菌体为主要组分的环境生物消毒剂及其应用 | |
CN102450973A (zh) | 一种含有柑橘精华的多功能湿巾 | |
CN103385804A (zh) | 防治口腔疾病的纳米银漱口水及其制备方法 | |
RU2481818C1 (ru) | Способ очистки и дезинфекции съемных зубных протезов | |
CN109122687A (zh) | 乙醇酸盐配合物杀菌剂及其应用 | |
CN102948426B (zh) | 一种食品安全级消毒液及其制备方法 | |
CN112972281A (zh) | 一种含水杨酸微胶囊的消毒级洗手液及其制备方法 | |
CN107333783A (zh) | 含茉莉酸甲酯的组合物在柑橘溃疡病的应用 | |
CN102846489B (zh) | 一种盐酸聚六亚甲基胍碘药浴液及其制备方法 | |
CN112220695A (zh) | 一种消毒免洗净手凝胶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Silver ion sterilizing dispersible tablet as well as preparation process and application thereof in removal of residual bacteria on fruits and vegetables Effective date of registration: 20141010 Granted publication date: 20140702 Pledgee: Gansu Ruitong Gould investment Company limited by guarantee Pledgor: LANZHOU TAITAN BIOTECHNOLOGY CO.,LTD.|Yan Zhaoliang Registration number: 2014620000005 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151217 Address after: Lin Lu Qilihe 730000 area in Gansu city of Lanzhou province No. 513 Patentee after: LANZHOU TAITAN BIOTECHNOLOGY CO.,LTD. Address before: 1302 B block, Central Plaza, Zhangye Road, Chengguan District, Gansu, Lanzhou 730030, China Patentee before: Yan Zhaoliang |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160229 Granted publication date: 20140702 Pledgee: Gansu double credit Company limited by guarantee Pledgor: LANZHOU TAITAN BIOTECHNOLOGY CO.,LTD.|Yan Zhaoliang Registration number: 2014620000005 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20160223 Registration number: 2014620000005 Pledgee after: Gansu double credit Company limited by guarantee Pledgee before: Gansu Ruitong Gould investment Company limited by guarantee |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160823 Address after: Lin Lu Qilihe 730000 area in Gansu city of Lanzhou province No. 513 Patentee after: LANZHOU TAITAN BIOTECHNOLOGY CO.,LTD. Address before: 1302 B block, Central Plaza, Zhangye Road, Chengguan District, Gansu, Lanzhou 730030, China Patentee before: Yan Zhaoliang |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200312 Address after: 730000 1st floor, building A5, No. 1139, north section of Songshan Road, Lanzhou New Area, Lanzhou City, Gansu Province Patentee after: Yan Zhaoliang Address before: Lin Lu Qilihe 730000 area in Gansu city of Lanzhou province No. 513 Patentee before: LANZHOU TAITAN BIOTECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200624 Address after: 730000 1st floor, building A5, No. 1139, north section of Songshan Road, Lanzhou New Area, Lanzhou City, Gansu Province Patentee after: Lanzhou Beilu Biotechnology Co.,Ltd. Address before: 730000 1st floor, building A5, No. 1139, north section of Songshan Road, Lanzhou New Area, Lanzhou City, Gansu Province Patentee before: Yan Zhaoliang |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140702 Termination date: 20220128 |
|
CF01 | Termination of patent right due to non-payment of annual fee |